EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy

Pankaj Yadav, Amit K Yadav iD, Dhiraj Bhatia iD

ACS Biomaterials Science & Engineering · 10.11.2025 · 11 (11) · 6401-6425

DOI: 10.1021/acsbiomaterials.5c01120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 07.10.2025. Verfasst von Pankaj Yadav und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Energy Technology, Pandit Deendayal Energy University, Knowledge Corridor, Gandhinagar, Gujarat 382007, India. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Nanoparticles, Immunotherapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 254 Literaturangaben. Gefördert von: Ministry of Earth Sciences, Science and Engineering Research Board, Board of Research in Nuclear Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) is a critical orchestrator of cancer progression, shaped not only by genetic mutations but also by dynamic factors such as acidic pH, dysregulated extracellular matrix (ECM), immunosuppressive cells, and cytokine networks. These elements collectively foster therapeutic resistance and metastasis, challenging conventional treatments. Nanotechnology has emerged as a transformative approach to dismantling TME barriers, enabling precise targeting and enhanced drug delivery. In addition, a key focus is overcoming ECM density and immunosuppression. For instance, ECM-degrading nanoparticles (NPs) loaded with hyaluronidase or collagenase improve drug penetration, while immune-modulating NPs reprogram macrophages from protumor (M2) to antitumor (M1) phenotypes. Complementing these strategies, advances in immune cell engineering, such as chimeric antigen receptor (CAR) T cells or natural killer (NK) cells, are synergized with NPs-delivered checkpoint inhibitors to amplify antitumor immunity. Additionally, pH-sensitive and enzyme-responsive NPs exploit TME-specific conditions for controlled drug release, minimizing systemic toxicity. Despite promising preclinical results, clinical translation faces hurdles. Challenges include optimizing NPs' biocompatibility, scalability, and long-term safety as well as addressing interpatient TME heterogeneity. Thus, this review explores innovative NPs designs engineered to navigate the TME complexity, including surface modifications with antibodies, folic acid, transferrin, peptides, and amino acids. These functionalized NPs improve tumor-specific targeting while evading immune clearance, thereby enhancing chemotherapeutic efficacy and reducing off-target effects. Moreover, this review evaluates current progress in NPs-based clinical trials targeting the TME and discusses emerging theranostic platforms that combine real-time imaging with therapy. By integration of multidisciplinary insights from materials science, immunology, and systems biology, nanotechnology holds immense potential to unlock personalized cancer therapies. Future research must prioritize scalable manufacturing and robust biomarker-driven approaches to realize this paradigm shift in oncology fully.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsNanoparticlesImmunotherapyNanoparticle Drug Delivery SystemNanotechnologyHumansExtracellular MatrixAnimals

Stichwörter der Autor:innen

cancer therapyimmune modulationnanoparticlessurface modificationtargeted drug deliverytumor microenvironment

Substanzen

Nanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Biotechnology, School of Energy Technology, Pandit Deendayal Energy University, Knowledge Corridor, Gandhinagar, Gujarat 382007, India.
  • Department of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar, Near Palaj, Gandhinagar, Gujarat 382355, India.

ORCID-Profile: Amit K Yadav, Dhiraj Bhatia

Förderung

  • Ministry of Earth Sciences
  • Science and Engineering Research Board
  • Board of Research in Nuclear Sciences
  • Ministry of Education, India
  • Gujarat Council on Science and Technology
  • Indian Institute of Technology Gandhinagar
  • Gujarat State Biotechnology Mission, Department of Science and Technology, Government of Gujarat
  • Higher Education Financing Agency, Ministry of Education, Government of India

Zitieren

APA

Yadav, P., Yadav, A. K., & Bhatia, D. (2025). Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy. ACS Biomaterials Science & Engineering, 11(11), 6401-6425. https://doi.org/10.1021/acsbiomaterials.5c01120

Vancouver

Yadav P, Yadav AK, Bhatia D. Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy. ACS Biomaterials Science & Engineering. 2025;11(11):6401-6425. doi:10.1021/acsbiomaterials.5c01120

BibTeX
@article{Yadav2025,
  author = {Yadav, Pankaj and Yadav, Amit K and Bhatia, Dhiraj},
  title = {Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  volume = {11},
  number = {11},
  pages = {6401--6425},
  doi = {10.1021/acsbiomaterials.5c01120}
}
Kostenlos starten →